#GLP1 #Diabetes #Type2Diabetes #ObesityTreatment #OralTherapy #EliLilly #Biotech #ClinicalTrials #HealthcareInnovation #Endocrinology #CardiometabolicHealth #WeightLoss #Pharmaceuticals #InvestorInsights #PatientCare #MedTech #LifeSciences #HealthTech #Semaglutide #GLP1 #EliLilly #Wegovy #Zepbound #Ozempic #Mounjaro #NovoNordisk #Sanofi # #Orforglipron #Marshallcapps #FDA #Regulation #Pharma #Healthcare #Biotech To view or add a comment, sign in Recent observational data suggest that liraglutide, semaglutide, and dulaglutide may offer comparable cardiovascular and kidney benefits in people with type 2 diabetes, while also delivering weight loss support
The Department of Justice prosecuted Tailor Made Compounding LLC, which pleaded guilty to distributing BPC-157 and other unapproved drugs, resulting in forfeiture of $1.79 million
Archives of Neurology, 37(12), 749753
When to Seek Medical Attention : Severe allergic reaction (itching, swelling, difficulty breathing) Chest pain or sudden weakness Drug Interactions : Can interfere with certain laboratory tests and may interact with medications like folic acid, requiring monitoring in some cases